MIBio2023 conference

18 October 2023 08:00-17:10, Cambridge , United Kingdom


Introduction
MIBio engages leading experts from industry and academia in a discussion on how the latest molecular interaction-based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly, and safer therapeutic products.

The 2023 meeting will focus on a number of aspects of cutting edge biopharmaceutical product development, including patient-centric dosage forms, both from the formulation and from the device point of view. In addition, for the first time in the MIBio series, recent advances and future outlook in oral delivery will be discussed. Last but not least, presentations and discussions will cover development of novel dosage forms and the use of artificial intelligence to achieve better products.

We expect around 100 delegates from biopharma industry, academia and technology suppliers to create a stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation of formulation technologies. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day.

We look forward to seeing you at MIBio 2023!
Venue
Downing College, University of Cambridge

Howard Theatre, Downing College, University of Cambridge, Regent Street , Cambridge , CB2 1DQ, United Kingdom

Committee
  • Jan Jezek Arecor, United Kingdom
  • Nicholas J Darton AstraZeneca, United Kingdom
  • Tejash Shah GSK, United Kingdom
  • Stephen Harding University of Nottingham, United Kingdom
  • Bernardo Perez-Ramirez Sanofi, United Kingdom
  • Bin Yang AstraZeneca, United Kingdom
  • Nacho Martin-Fabiani-Carrato Loughborough University, United Kingdom

Organised by
Royal Society of Chemistry
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*